"10.1371_journal.pone.0085459","plos one","2014-01-21T00:00:00Z","Laura L Hammitt; John Ojal; Mahfudh Bashraheil; Susan C Morpeth; Angela Karani; Ahsan Habib; Dorota Borys; David Goldblatt; J Anthony G Scott","KEMRI-Wellcome Trust Research Programme, Centre for Geographic Medicine-Coast, Kilifi, Kenya; Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, United States of America; Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom; GlaxoSmithKline Vaccines, Wavre, Belgium; Institute of Child Health, University College London, London, United Kingdom; Department of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, United Kingdom","Conceived and designed the experiments: LLH JAGS. Performed the experiments: MB AK DG. Analyzed the data: LLH JO MB SCM DG JAGS. Contributed reagents/materials/analysis tools: LLH JO SCM AK DG JAGS. Wrote the paper: LLH JO SCM AH DB DG JAGS.","The authors have the following interests. This was an investigator-initiated trial funded by GlaxoSmithKline Biologicals. D.B. and A.H. are employed by the GlaxoSmithKline group of companies and have GSK stock/stock options ownership. J.A.G.S. and L.L.H. have received research funding from GlaxoSmithKline Biologicals. J.A.G.S. has received support for travel/accommodation at a scientific meeting sponsored by Merck. D.G. has participated in advisory boards and received honoraria and consultancy fees from Pfizer (formerly Wyeth Vaccines). There are no patents, products in development or marketed products to declare. This does not alter the authorsâ€² adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.","2014","01","Laura L Hammitt","LLH",9,TRUE,2,3,6,7,TRUE,TRUE,FALSE,0,NA,FALSE
